Concepedia

Matthew Sims

MS

Statistics

Publications

31

Citations

1.5K

H-Index

21

Active since

1991

Affiliations

Oakland University(Current)

Beaumont Health

Beaumont Hospital, Royal Oak

University of California, Davis

Henry Ford Health System

Matthew Sims is an author at Oakland University specializing in medicine, infection control, and antibiotics.

ORCID

Top concepts

Publications per year

1991–2024

31

Publications

31

Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infections

Matthew Sims, Valeri Mariyanovski, Patrick McLeroth et al. · Journal of Antimicrobial Chemotherapy · 2017 · 158 citations · Full text

The Emperor’s New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among ADult HospitalizEd Patients With Methicillin-resistant Staphylococcus aureus Bloodstream Infections (PROVIDE)

Thomas P. Lodise, Susan L. Rosenkranz, Matthew Finnemeyer et al. · Clinical Infectious Diseases · 2019 · 151 citations · Full text

Bile salt hydrolase acyltransferase activity expands bile acid diversity

Douglas V. Guzior, Maxwell Okros, Madison Shivel et al. · Nature · 2024 · 125 citations

, , +1

Colistin Monotherapy versus Combination Therapy for Carbapenem-Resistant Organisms

Keith S. Kaye, Dror Marchaim, Visanu Thamlikitkul et al. · NEJM Evidence · 2022 · 124 citations · Full text

Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019

Richard M. Burwick, Sigal Yawetz, Kathryn E. Stephenson et al. · Clinical Infectious Diseases · 2020 · 119 citations · Full text

1–5 of 31